Drug Discovery

Can Subcutaneous Saphnelo Transform Lupus Treatment?
Biotech & Bioprocessing Can Subcutaneous Saphnelo Transform Lupus Treatment?

What happens when a chronic disease like systemic lupus erythematosus (SLE) steals not just health, but the very essence of daily life from millions worldwide, leaving them to grapple with relentless pain, fatigue, and organ damage? For over 3.4 million people battling this autoimmune condition, a

Breakthrough Drug-Diet Combo Targets Neuroblastoma in Kids
Research & Development Breakthrough Drug-Diet Combo Targets Neuroblastoma in Kids

Neuroblastoma, a devastating cancer affecting primarily children under five, stands as one of the most aggressive solid tumors in pediatric populations, with high-risk cases often showing dismal outcomes despite rigorous treatments. With only about half of these young patients achieving a cure

Neurons Burn Fat for Energy: A Breakthrough for Brain Disorders
Research & Development Neurons Burn Fat for Energy: A Breakthrough for Brain Disorders

Imagine a world where the brain's fundamental energy processes, long thought to be set in stone, are suddenly redefined by a single discovery that could alter the course of treatment for devastating neurological conditions. Researchers from prestigious institutions have recently unveiled a

Can Ribosomes Revolutionize Drug Design with Cyclic Peptides?
Biotech & Bioprocessing Can Ribosomes Revolutionize Drug Design with Cyclic Peptides?

Imagine a world where the tiniest cellular machines, responsible for crafting the building blocks of life, are harnessed to create powerful new drugs capable of targeting diseases with unprecedented precision, and this vision is inching closer to reality thanks to groundbreaking research in

Why Is Johnson & Johnson Facing a $966M Talc Verdict?
Research & Development Why Is Johnson & Johnson Facing a $966M Talc Verdict?

In a stunning turn of events that has captured national attention, a Los Angeles jury recently ordered Johnson & Johnson, a multinational giant in the healthcare industry, to pay a staggering $966 million to the family of Mae Moore, a California resident who tragically passed away in 2021 from

Roche's Giredestrant Delays Breast Cancer Progression
Research & Development Roche's Giredestrant Delays Breast Cancer Progression

Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies in the pharmaceutical industry. With his deep understanding of cutting-edge treatments, Ivan is the perfect

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later